Glutaric acidemia type 2 (English Wikipedia)

Analysis of information sources in references of the Wikipedia article "Glutaric acidemia type 2" in English language version.

refsWebsite

Global rank English rank

9nih.gov

4^th place

5doi.org

2^nd place

2worldcat.org

5^th place

2web.archive.org

1^st place

2semanticscholar.org

11^th place

8^th place

1omim.org

4,380^th place

4,305^th place

1orpha.net

3,537^th place

7,177^th place

1aappublications.org

3,763^rd place

3,602^nd place

aappublications.org

pediatrics.aappublications.org

Van Rijt WJ, Heiner-Fokkema MR, du Marchie Sarvaas GJ, Waterham HR, Blokpoel RG, van Spronsen FJ, Derks TG (October 2014). "Favorable outcome after physiologic dose of sodium-D,L-3-hydroxybutyrate in severe MADD". Pediatrics. 134 (4): e1224-8. doi:10.1542/peds.2013-4254. PMID 25246622. S2CID 16829114. Retrieved 30 August 2018.

doi.org

Henriques, Bárbara J.; Katrine Jentoft Olsen, Rikke; Gomes, Cláudio M.; Bross, Peter (2021-04-15). "Electron transfer flavoprotein and its role in mitochondrial energy metabolism in health and disease". Gene. 776: 145407. doi:10.1016/j.gene.2021.145407. ISSN 1879-0038. PMC 7949704. PMID 33450351.
Béhin, A.; Acquaviva-Bourdain, C.; Souvannanorath, S.; Streichenberger, N.; Attarian, S.; Bassez, G.; Brivet, M.; Fouilhoux, A.; Labarre-Villa, A.; Laquerrière, A.; Pérard, L.; Kaminsky, P.; Pouget, J.; Rigal, O.; Vanhulle, C. (March 2016). "Multiple acyl-CoA dehydrogenase deficiency (MADD) as a cause of late-onset treatable metabolic disease". Revue Neurologique. 172 (3): 231–241. doi:10.1016/j.neurol.2015.11.008. ISSN 0035-3787. PMID 27038534.
Gautschi M, Weisstanner C, Slotboom J, Nava E, Zürcher T, Nuoffer JM (January 2015). "Highly efficient ketone body treatment in multiple acyl-CoA dehydrogenase deficiency-related leukodystrophy". Pediatr Res. 77 (1): 91–8. doi:10.1038/pr.2014.154. PMID 25289702.
Van Rijt WJ, Heiner-Fokkema MR, du Marchie Sarvaas GJ, Waterham HR, Blokpoel RG, van Spronsen FJ, Derks TG (October 2014). "Favorable outcome after physiologic dose of sodium-D,L-3-hydroxybutyrate in severe MADD". Pediatrics. 134 (4): e1224-8. doi:10.1542/peds.2013-4254. PMID 25246622. S2CID 16829114. Retrieved 30 August 2018.
Van Hove JL, Grünewald S, Jaeken J, Demaerel P, Declercq PE, Bourdoux P, Niezen-Koning K, Deanfeld JE, Leonard JV (26 April 2003). "D,L-3-hydroxybutyrate treatment of multiple acyl-CoA dehydrogenase deficiency (MADD)". The Lancet. 361 (9367): 1433–5. doi:10.1016/S0140-6736(03)13105-4. PMID 12727399. S2CID 25397192.

nih.gov

pubmed.ncbi.nlm.nih.gov

Henriques, Bárbara J.; Katrine Jentoft Olsen, Rikke; Gomes, Cláudio M.; Bross, Peter (2021-04-15). "Electron transfer flavoprotein and its role in mitochondrial energy metabolism in health and disease". Gene. 776: 145407. doi:10.1016/j.gene.2021.145407. ISSN 1879-0038. PMC 7949704. PMID 33450351.
Béhin, A.; Acquaviva-Bourdain, C.; Souvannanorath, S.; Streichenberger, N.; Attarian, S.; Bassez, G.; Brivet, M.; Fouilhoux, A.; Labarre-Villa, A.; Laquerrière, A.; Pérard, L.; Kaminsky, P.; Pouget, J.; Rigal, O.; Vanhulle, C. (March 2016). "Multiple acyl-CoA dehydrogenase deficiency (MADD) as a cause of late-onset treatable metabolic disease". Revue Neurologique. 172 (3): 231–241. doi:10.1016/j.neurol.2015.11.008. ISSN 0035-3787. PMID 27038534.
Gautschi M, Weisstanner C, Slotboom J, Nava E, Zürcher T, Nuoffer JM (January 2015). "Highly efficient ketone body treatment in multiple acyl-CoA dehydrogenase deficiency-related leukodystrophy". Pediatr Res. 77 (1): 91–8. doi:10.1038/pr.2014.154. PMID 25289702.
Van Rijt WJ, Heiner-Fokkema MR, du Marchie Sarvaas GJ, Waterham HR, Blokpoel RG, van Spronsen FJ, Derks TG (October 2014). "Favorable outcome after physiologic dose of sodium-D,L-3-hydroxybutyrate in severe MADD". Pediatrics. 134 (4): e1224-8. doi:10.1542/peds.2013-4254. PMID 25246622. S2CID 16829114. Retrieved 30 August 2018.
Van Hove JL, Grünewald S, Jaeken J, Demaerel P, Declercq PE, Bourdoux P, Niezen-Koning K, Deanfeld JE, Leonard JV (26 April 2003). "D,L-3-hydroxybutyrate treatment of multiple acyl-CoA dehydrogenase deficiency (MADD)". The Lancet. 361 (9367): 1433–5. doi:10.1016/S0140-6736(03)13105-4. PMID 12727399. S2CID 25397192.

omim.org

"#231680 - MULTIPLE ACYL-CoA DEHYDROGENASE DEFICIENCY; MADD". www.omim.org. Retrieved 2023-12-06.

orpha.net

"Multiple acyl-CoA dehydrogenase deficiency". Orphanet. INSERM and the European Commission. Retrieved 30 August 2018.

semanticscholar.org

api.semanticscholar.org

Van Rijt WJ, Heiner-Fokkema MR, du Marchie Sarvaas GJ, Waterham HR, Blokpoel RG, van Spronsen FJ, Derks TG (October 2014). "Favorable outcome after physiologic dose of sodium-D,L-3-hydroxybutyrate in severe MADD". Pediatrics. 134 (4): e1224-8. doi:10.1542/peds.2013-4254. PMID 25246622. S2CID 16829114. Retrieved 30 August 2018.
Van Hove JL, Grünewald S, Jaeken J, Demaerel P, Declercq PE, Bourdoux P, Niezen-Koning K, Deanfeld JE, Leonard JV (26 April 2003). "D,L-3-hydroxybutyrate treatment of multiple acyl-CoA dehydrogenase deficiency (MADD)". The Lancet. 361 (9367): 1433–5. doi:10.1016/S0140-6736(03)13105-4. PMID 12727399. S2CID 25397192.

web.archive.org

"Glutaric acidemia type II". Genetic and Rare Diseases Information Center. Archived from the original on 21 September 2021. Retrieved 23 February 2023.
"Glutaric acidemia type II". Genetic and Rare Diseases Information Center (GARD). National Institutes of Health National Center for Advancing Translational Sciences. Archived from the original on 21 September 2021. Retrieved 30 August 2018.

worldcat.org

search.worldcat.org

Henriques, Bárbara J.; Katrine Jentoft Olsen, Rikke; Gomes, Cláudio M.; Bross, Peter (2021-04-15). "Electron transfer flavoprotein and its role in mitochondrial energy metabolism in health and disease". Gene. 776: 145407. doi:10.1016/j.gene.2021.145407. ISSN 1879-0038. PMC 7949704. PMID 33450351.
Béhin, A.; Acquaviva-Bourdain, C.; Souvannanorath, S.; Streichenberger, N.; Attarian, S.; Bassez, G.; Brivet, M.; Fouilhoux, A.; Labarre-Villa, A.; Laquerrière, A.; Pérard, L.; Kaminsky, P.; Pouget, J.; Rigal, O.; Vanhulle, C. (March 2016). "Multiple acyl-CoA dehydrogenase deficiency (MADD) as a cause of late-onset treatable metabolic disease". Revue Neurologique. 172 (3): 231–241. doi:10.1016/j.neurol.2015.11.008. ISSN 0035-3787. PMID 27038534.